Orange Belgium SA (OBEL)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 22.20 |
|---|---|
| 52-week range | 17.90 – 22.40 |
| Return, 1 month / 3 months | +0.5% / +1.8% |
| Return, 1 year / 3 years | +16.2% / +59.5% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 8.8% |
| Worst drawdown (1 year) | -3.9% |
| Average daily value traded | 0.03M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Orange Belgium is a telecommunications operator serving customers in Belgium. It offers mobile voice and data services, fixed broadband and television packages to households, along with connectivity and communication services for businesses and public organisations. The company also provides wholesale access to its networks for other operators. It is based in Brussels and operates under the Orange brand as part of the wider Orange group.
The shares are listed on the Euronext Brussels in Belgium under the code OBEL, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Orange Belgium SA (OBEL) trades on the Euronext Brussels in Belgium. It last closed at EUR 22.20 on 22 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 8 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.2% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.3% | ||
| From 52-week high | -0.4% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | 8.3% | ||
| 12-month return, skipping the last month | 15.7% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 8.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -3.9% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.9% |
|---|---|
| 1 month | +0.5% |
| 3 months | +1.8% |
| 6 months | +8.3% |
| 1 year | +16.2% |
| 3 years | +59.5% |
| 5 years | +12.6% |
Signals
| 50-day / 200-day average | 22.12 / 21.09 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2021 | EUR 0.3500 |
| 12 May 2020 | EUR 0.3500 |
| 14 May 2019 | EUR 0.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.